dr. o’malley on research with immunotherapy in ovarian cancer
Published 4 years ago • 90 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:08
dr. o’malley on the state of immunotherapy in ovarian cancer
-
1:35
dr. o’malley on ongoing clinical trials evaluating immunotherapy in ovarian cancer
-
1:15
dr. o’malley on remaining questions in ovarian cancer
-
0:58
dr. o’malley on the utility of mirvetuximab in ovarian cancer
-
1:47
dr. o’malley on antitumor activity with veliparib combo in serous ovarian cancer
-
1:00
dr. o’malley on the forward ii phase ib study in ovarian cancer
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
1:35
dr. coleman on immunotherapy in ovarian cancer
-
1:11
dr. o'malley on toxicity profiles of parp inhibitors in ovarian cancer
-
1:34
dr. moore on challenges with immunotherapy in ovarian cancer
-
1:37
dr. hays on immunotherapy in ovarian cancer treatment
-
1:13
dr. o’malley on the activity of mirvetuximab soravtansine in ovarian cancer
-
1:18
dr. o'malley on the tolerability of parp inhibitors in ovarian cancer
-
1:49
dr. konstantinopoulos on immunotherapy in ovarian cancer
-
0:54
research to advance immunotherapy for ovarian cancer
-
1:27
brian slomovitz, md, elaborates on the role of immunotherapy in ovarian cancer
-
3:47
rationale for immunotherapy in ovarian cancer
-
0:51
dr. o'malley on folate-receptor alpha as a biomarker in ovarian cancer